KEGG (KYOTO ENCYCLOPEDIA OF GENES AND GENOMES) is a collection of databases dealing with genomes , biological pathways , diseases , drugs , and chemical substances . KEGG is utilized for bioinformatics research and education, including data analysis in genomics , metagenomics , metabolomics and other omics studies, modeling and simulation in systems biology , and translational research in drug development .
* 1 Introduction
* 2 Databases
* 2.1 Systems information * 2.2 Genomic information * 2.3 Chemical information * 2.4 Health information
* 3 Subscription model * 4 See also * 5 References * 6 External links
The KEGG database project was initiated in 1995 by Minoru Kanehisa, Professor at the Institute for Chemical Research, Kyoto University , under the then ongoing Japanese Human Genome Program . Foreseeing the need for a computerized resource that can be used for biological interpretation of genome sequence data , he started developing the KEGG PATHWAY database. It is a collection of manually drawn KEGG pathway maps representing experimental knowledge on metabolism and various other functions of the cell and the organism . Each pathway map contains a network of molecular interactions and reactions and is designed to link genes in the genome to gene products (mostly proteins ) in the pathway. This has enabled the analysis called KEGG pathway mapping, whereby the gene content in the genome is compared with the KEGG PATHWAY database to examine which pathways and associated functions are likely to be encoded in the genome.
According to the developers, KEGG is a "computer representation" of the biological system . It integrates building blocks and wiring diagrams of the system — more specifically, genetic building blocks of genes and proteins, chemical building blocks of small molecules and reactions, and wiring diagrams of molecular interaction and reaction networks. This concept is realized in the following databases of KEGG, which are categorized into systems, genomic, chemical, and health information.
* Systems information
* PATHWAY — pathway maps for cellular and organismal functions * MODULE — modules or functional units of genes * BRITE — hierarchical classifications of biological entities
* Genomic information
* GENOME — complete genomes * GENES — genes and proteins in the complete genomes * ORTHOLOGY — ortholog groups of genes in the complete genomes
* Chemical information
* COMPOUND, GLYCAN — chemical compounds and glycans * REACTION, RPAIR, RCLASS — chemical reactions * ENZYME — enzyme nomenclature
* Health information
* DISEASE — human diseases * DRUG — approved drugs * ENVIRON — crude drugs and health-related substances
The KEGG PATHWAY database, the wiring diagram database, is the core of the KEGG resource. It is a collection of pathway maps integrating many entities including genes, proteins, RNAs, chemical compounds, glycans, and chemical reactions, as well as disease genes and drug targets, which are stored as individual entries in the other databases of KEGG. The pathway maps are classified into the following sections:
* Metabolism * Genetic information processing (transcription , translation , replication and repair , etc.) * Environmental information processing (membrane transport , signal transduction , etc.) * Cellular processes (cell growth , cell death , cell membrane functions, etc.) * Organismal systems (immune system , endocrine system , nervous system , etc.) * Human diseases * Drug development
The metabolism section contains aesthetically drawn global maps showing an overall picture of metabolism, in addition to regular metabolic pathway maps. The low-resolution global maps can be used, for example, to compare metabolic capacities of different organisms in genomics studies and different environmental samples in metagenomics studies. In contrast, KEGG modules in the KEGG MODULE database are higher-resolution, localized wiring diagrams, representing tighter functional units within a pathway map, such as subpathways conserved among specific organism groups and molecular complexes. KEGG modules are defined as characteristic gene sets that can be linked to specific metabolic capacities and other phenotypic features, so that they can be used for automatic interpretation of genome and metagenome data.
Another database that supplements KEGG PATHWAY is the KEGG BRITE database. It is an ontology database containing hierarchical classifications of various entities including genes, proteins, organisms, diseases, drugs, and chemical compounds. While KEGG PATHWAY is limited to molecular interactions and reactions of these entities, KEGG BRITE incorporates many different types of relationships.
Several months after the KEGG project was initiated in 1995, the first report of the completely sequenced bacterial genome was published. Since then all published complete genomes are accumulated in KEGG for both eukaryotes and prokaryotes . The KEGG GENES database contains gene/protein-level information and the KEGG GENOME database contains organism-level information for these genomes. The KEGG GENES database consists of gene sets for the complete genomes, and genes in each set are given annotations in the form of establishing correspondences to the wiring diagrams of KEGG pathway maps, KEGG modules, and BRITE hierarchies.
These correspondences are made using the concept of orthologs . The KEGG pathway maps are drawn based on experimental evidence in specific organisms but they are designed to be applicable to other organisms as well, because different organisms, such as human and mouse, often share identical pathways consisting of functionally identical genes, called orthologous genes or orthologs. All the genes in the KEGG GENES database are being grouped into such orthologs in the KEGG ORTHOLOGY (KO) database. Because the nodes (gene products) of KEGG pathway maps, as well as KEGG modules and BRITE hierarchies, are given KO identifiers, the correspondences are established once genes in the genome are annotated with KO identifiers by the genome annotation procedure in KEGG.
The KEGG metabolic pathway maps are drawn to represent the dual aspects of the metabolic network: the genomic network of how genome-encoded enzymes are connected to catalyze consecutive reactions and the chemical network of how chemical structures of substrates and products are transformed by these reactions. A set of enzyme genes in the genome will identify enzyme relation networks when superimposed on the KEGG pathway maps, which in turn characterize chemical structure transformation networks allowing interpretation of biosynthetic and biodegradation potentials of the organism. Alternatively, a set of metabolites identified in the metabolome will lead to the understanding of enzymatic pathways and enzyme genes involved.
The databases in the chemical information category, which are collectively called KEGG LIGAND, are organized by capturing knowledge of the chemical network. In the beginning of the KEGG project, KEGG LIGAND consisted of three databases: KEGG COMPOUND for chemical compounds, KEGG REACTION for chemical reactions, and KEGG ENZYME for reactions in the enzyme nomenclature. Currently, there are additional databases: KEGG GLYCAN for glycans and two auxiliary reaction databases called RPAIR (reactant pair alignments) and RCLASS (reaction class). KEGG COMPOUND has also been expanded to contain various compounds such as xenobiotics , in addition to metabolites.
In KEGG, diseases are viewed as perturbed states of the biological system caused by perturbants of genetic factors and environmental factors, and drugs are viewed as different types of perturbants. The KEGG PATHWAY database includes not only the normal states but also the perturbed states of the biological systems. However, disease pathway maps cannot be drawn for most diseases because molecular mechanisms are not well understood. An alternative approach is taken in the KEGG DISEASE database, which simply catalogs known genetic factors and environmental factors of diseases. These catalogs may eventually lead to more complete wiring diagrams of diseases.
The KEGG DRUG database contains active ingredients of approved drugs in Japan, the USA, and Europe. They are distinguished by chemical structures and/or chemical components and associated with target molecules, metabolizing enzymes , and other molecular interaction network information in the KEGG pathway maps and the BRITE hierarchies. This enables an integrated analysis of drug interactions with genomic information. Crude drugs and other health-related substances, which are outside of the category of approved drugs, are stored in the KEGG ENVIRON database. The databases in the health information category are collectively called KEGG MEDICUS, which also includes package inserts of all marketed drugs in Japan.
In July 2011 KEGG introduced a subscription model for FTP download due to a significant cutback of government funding. KEGG continues to be freely available through its website, but the subscription model has raised discussions about sustainability of bioinformatics databases.
* Comparative Toxicogenomics Database - CTD integrates KEGG pathways with toxicogenomic and disease data * ConsensusPathDB , a molecular functional interaction database, integrating information from KEGG * Gene ontology * PubMed * Uniprot * Gene Disease Database
* ^ Kanehisa M, Goto S (2000). "KEGG: Kyoto Encyclopedia of Genes and Genomes" . _Nucleic Acids Res_. 28 (1): 27–30. PMC 102409 _. PMID 10592173 . doi :10.1093/nar/28.1.27 . * ^ Kanehisa M (1997). "A database for post-genome analysis". Trends Genet_. 13 (9): 375–6. PMID 9287494 . doi :10.1016/S0168-9525(97)01223-7 . * ^ Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M (2006). "From genomics to chemical genomics: new developments in KEGG" . _Nucleic Acids Res_. 34 (Database issue): D354–7. PMC 1347464 _. PMID 16381885 . doi :10.1093/nar/gkj102 . * ^ A_ _B_ Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M (2014). "Data, information, knowledge and principle: back to metabolism in KEGG" . _Nucleic Acids Res_. 42 (Database issue): D199–205. PMC 3965122 _. PMID 24214961 . doi :10.1093/nar/gkt1076 . * ^ Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al. (1995). "Whole-genome random sequencing and assembly of Haemophilus influenzae Rd". Science_. 269 (5223): 496–512. PMID 7542800 . doi :10.1126/science.7542800 . * ^ Kanehisa M (2013). "Chemical and genomic evolution of enzyme-catalyzed reaction networks". _FEBS Lett_. 587 (17): 2731–7. PMID 23816707 . doi :10.1016/j.febslet.2013.06.026 . * ^ Goto S, Nishioka T, Kanehisa M (1999). "LIGAND database for enzymes, compounds and reactions" . _Nucleic Acids Res_. 27 (1): 377–9. PMC 148189 _. PMID 9847234 . doi :10.1093/nar/27.1.377 . * ^ Hashimoto K, Goto S, Kawano S, Aoki-Kinoshita KF, Ueda N, Hamajima M, Kawasaki T, Kanehisa M (2006). " KEGG as a glycome informatics resource". Glycobiology_. 16 (5): 63R–70R. PMID 16014746 . doi :10.1093/glycob/cwj010 . * ^ Muto A, Kotera M, Tokimatsu T, Nakagawa Z, Goto S, Kanehisa M (2013). "Modular architecture of metabolic pathways revealed by conserved sequences of reactions" . _J Chem Inf Model_. 53 (3): 613–22. PMC 3632090 _. PMID 23384306 . doi :10.1021/ci3005379 . * ^ Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010). " KEGG for representation and analysis of molecular networks involving diseases and drugs" . Nucleic Acids Res_. 38 (Database issue): D355–60. PMC 2808910 _. PMID 19880382 . doi :10.1093/nar/gkp896 .
* ^ Galperin MY, Fernández-Suárez XM (2012). "The 2012 Nucleic Acids Research Database Issue and the online Molecular Biology Database Collection" . Nucleic Acids Res_. 40 (Database issue): D1–8. PMC 3245068 . PMID 22144685 . doi :10.1093/nar/gkr1196 . * ^ Hayden, EC. "Popular plant database set to charge users".